» Articles » PMID: 12079288

A Novel Gene Encoding a TIG Multiple Domain Protein is a Positional Candidate for Autosomal Recessive Polycystic Kidney Disease

Overview
Journal Genomics
Specialty Genetics
Date 2002 Jun 25
PMID 12079288
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Autosomal recessive polycystic kidney disease (ARPKD) is a common hereditary renal cystic disease in infants and children. By genetic linkage analyses, the gene responsible for this disease, termed polycystic kidney and hepatic disease 1 (PKHD1), was mapped on human chromosome 6p21.1-p12, and has been further localized to a 1-cM genetic interval flanked by the D6S1714/D6S243 (telomeric) and D6S1024 (centromeric) markers. We recently identified a novel gene in this genetic interval from kidney cDNA, using cloning strategies. The gene PKHD1 (PKHD1-tentative) encodes a novel 3396-amino-acid protein with no apparent homology with any known proteins. We named its gene product "tigmin" because it contains multiple TIG domains, which usually are seen in proteins containing immunoglobulin-like folds. PKHD1 encodes an 11.6-kb transcript and is composed of 61 exons spanning an approximately 365-kb genomic region on chromosome 6p12-p11.2 adjacent to the marker D6S1714. Northern blot analyses demonstrated that the gene has discrete bands with one peak signal at approximately 11 kb, indicating that PKHD1 is likely to have multiple alternative transcripts. PKHD1 is highly expressed in adult and infant kidneys and weakly expressed in liver in northern blot analysis. This expression pattern parallels the tissue involvement observed in ARPKD. In situ hybridization analysis further revealed that the expression of PKHD1 in the kidney is mainly localized to the epithelial cells of the collecting duct, the specific tubular segment involved in cyst formation in ARPKD. These features of PKHD1 make it a strong positional candidate gene for ARPKD.

Citing Articles

Differential regulation of MYC expression by in human and mouse kidneys: phenotypic implications for recessive polycystic kidney disease.

Harafuji N, Yang C, Wu M, Thiruvengadam G, Gordish-Dressman H, Thompson R Front Cell Dev Biol. 2023; 11:1270980.

PMID: 38125876 PMC: 10731465. DOI: 10.3389/fcell.2023.1270980.


Pkhd1 mice have altered renal Pkhd1 mRNA processing and hormonally sensitive liver disease.

Yang C, Harafuji N, Caldovic L, Yu W, Boddu R, Bhattacharya S J Mol Med (Berl). 2023; 101(9):1141-1151.

PMID: 37584738 PMC: 10482757. DOI: 10.1007/s00109-023-02351-2.


The Biology of Vasopressin.

Sparapani S, Millet-Boureima C, Oliver J, Mu K, Hadavi P, Kalostian T Biomedicines. 2021; 9(1).

PMID: 33477721 PMC: 7832310. DOI: 10.3390/biomedicines9010089.


Use of patient derived urine renal epithelial cells to confirm pathogenicity of PKHD1 alleles.

Molinari E, Srivastava S, Dewhurst R, Sayer J BMC Nephrol. 2020; 21(1):435.

PMID: 33059616 PMC: 7559414. DOI: 10.1186/s12882-020-02094-z.


A Novel Mutation Interacts with the Nonobese Diabetic Genetic Background To Cause Autoimmune Cholangitis.

Huang W, Rainbow D, Wu Y, Adams D, Shivakumar P, Kottyan L J Immunol. 2017; 200(1):147-162.

PMID: 29158418 PMC: 5757511. DOI: 10.4049/jimmunol.1701087.